GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » Tax Expense

Bangkok Genomics Innovation PCL (BKK:BKGI) Tax Expense : ฿0.9 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL Tax Expense?

Bangkok Genomics Innovation PCL's tax expense for the months ended in Dec. 2024 was ฿0.5 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was ฿0.9 Mil.


Bangkok Genomics Innovation PCL Tax Expense Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL Tax Expense Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Tax Expense
Get a 7-Day Free Trial -0.51 0.27 3.55 -0.20 0.86

Bangkok Genomics Innovation PCL Quarterly Data
Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.02 -0.02 0.42 0.48

Bangkok Genomics Innovation PCL Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bangkok Genomics Innovation PCL  (BKK:BKGI) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Bangkok Genomics Innovation PCL Tax Expense Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL Business Description

Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.

Bangkok Genomics Innovation PCL Headlines